Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

S&P Pharmaceuticals SPDR (XPH)

S&P Pharmaceuticals SPDR (XPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 10.54
  • Annual Dividend & Yield 0.70 (1.52%)
  • Most Recent Dividend 0.195 on 09/23/24
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 21.26% ( +0.23%)
  • Historical Volatility 16.54%
  • IV Percentile 93%
  • IV Rank 84.11%
  • IV High 24.83% on 08/14/24
  • IV Low 2.35% on 06/11/24
  • Put/Call Vol Ratio 1.00
  • Today's Volume 2
  • Volume Avg (30-Day) 94
  • Put/Call OI Ratio 5.03
  • Today's Open Interest 1,169
  • Open Int (30-Day) 1,110

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.52 +4.68%
on 10/10/24
47.41 -3.91%
on 10/18/24
+1.02 (+2.28%)
since 10/04/24
3-Month
40.50 +12.49%
on 08/09/24
47.41 -3.91%
on 10/18/24
+3.73 (+8.91%)
since 08/05/24
52-Week
34.67 +31.40%
on 11/13/23
47.41 -3.91%
on 10/18/24
+8.23 (+22.04%)
since 11/03/23

Most Recent Stories

More News
Do Wall Street Analysts Like Catalent Stock?

While Catalent has outperformed the broader market over the past year, analysts are cautious about the stock’s potential.

CTLT : 58.67 (-0.03%)
$SPX : 5,757.75 (+0.79%)
XPH : 45.56 (-0.92%)
BCS : 12.86 (+1.42%)
Zoetis Stock: Is Wall Street Bullish or Bearish?

Despite Zoetis lagging behind the broader market over the past year, analysts still remain strongly bullish on the stock’s prospects.

ZTS : 175.57 (+0.22%)
$SPX : 5,757.75 (+0.79%)
XPH : 45.56 (-0.92%)
How Is Bristol-Myers Squibb's Stock Performance Compared to Other General Drug Manufacturers?

Bristol-Myers Squibb has been lagging behind other drug manufacturers over the past three months, and analysts remain cautious about the stock's prospects.

BMY : 55.46 (+0.02%)
XPH : 45.56 (-0.92%)
AZN : 65.87 (-7.78%)
Do Wall Street Analysts Like Merck & Company Stock?

As Merck outperforms the broader market this year, Wall Street analysts remain optimistic about the stock's prospects.

MRK : 101.47 (-0.39%)
$SPX : 5,757.75 (+0.79%)
XPH : 45.56 (-0.92%)
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

AMGN : 317.15 (+0.08%)
BMY : 55.46 (+0.02%)
LLY : 799.60 (-0.81%)
XLV : 147.13 (+0.25%)
HZNP : 116.30 (+0.04%)
JNJ : 157.77 (-0.30%)
MRK : 101.47 (-0.39%)
NVS : 108.74 (-1.61%)
NVO : 109.06 (-0.60%)
XPH : 45.56 (-0.92%)
ALPMY : 11.3500 (-3.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 46.65
2nd Resistance Point 46.47
1st Resistance Point 46.23
Last Price 45.56
1st Support Level 45.81
2nd Support Level 45.63
3rd Support Level 45.39

See More

52-Week High 47.41
Last Price 45.56
Fibonacci 61.8% 42.54
Fibonacci 50% 41.04
Fibonacci 38.2% 39.54
52-Week Low 34.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar